In a recent study, we identified 34 transcripts that were differentially expressed in NASH patients with or without fibrosis [9], nine of which overlapped with predicted AEBP1 target genes identified by bioinformatic analysis [20]. The gene discussed is AEBP1; the disease is metabolic dysfunction-associated steatohepatitis.